October 23(Wed) 08:30-10:10 |
Symposium 18 Cytokine-blockade Therapy of Human Diseases |
Room A | ||
---|---|---|---|---|
Speaker(s) |
Anti-T2 biologics in severe asthma
Ian Adcock (Imperial College London, GBR) |
|||
Role of CXCR6+CD4+ Tissue-Resident Memory T Cells in Chronic Allergic Skin Inflammation
Kenji Kabashima (Kyoto Univ., JPN) |
||||
The multifaceted contribution of the BAFF/APRIL system to Chronic Lymphocytic Leukemia progression
Fabienne Mackay (QIMR Berghofer Medical Research Institute, AUS) |
October 23(Wed) 08:30-10:10 |
Symposium 19 Cytokines in T helper Differentiation and Function |
Room B | ||
---|---|---|---|---|
Speaker(s) |
Gene dosage control by multi-enhancer hub formation
Golnaz Vahedi (Univ. of Pennsylvania, USA) |
|||
Neuronal Control of Cutaneous Inflammation
Daniel Kaplan (Univ. of Pittsburgh, USA) |
||||
Non-canonical regulation of IL-21 bioavailability and activity
Di Yu (The Univ. of Queensland, AUS) |
October 23(Wed) 13:30-14:30 |
Keynote | Room A | ||
---|---|---|---|---|
Speaker(s) |
Nucleoside Modified mRNA-LNP Therapeutics
Drew Weissman (Univ. of Pennsylvania, USA) |